On ECHEMI
Home > Drugs > Chongqing KERUI Pharmaceutical (GROUP) Co., Ltd.
Chongqing KERUI Pharmaceutical (GROUP) Co., Ltd.
  • Founded in:

    1999-03-03
  • Country:

    China China
  • Address:

    No. 2 Dashizhi Road, Nan'an Economic and Technological Development Zone, Chongqing
  • Tax NO.:

    915001082031636780
  • Registered Funds:

    110.6375 million yuan
  • Website:

  • Email:

Related Drugs
Ranitidine Hydrochloride Capsules
Ranitidine hydrochloride, its chemical name is: N'-methyl-N-[2-[[[5-[(dimethylamino)methyl]-2-furyl]-methyl]thio]ethyl]-2-nitro-1,1-ethylenediamine hydrochloride.
Name Description Content CAS NO. Registered Holders
Ranitidine Hydrochloride

It has the effect of competitively blocking the binding of histamine to H2 receptors. Its inhibitory effect on gastric acid is 5 to 12 times that of cimetidine in terms of moles. Therefore, it is a potent H2 receptor blocker.

More

It has the effect of competitively blocking the binding of histamine to H2 receptors. Its inhibitory effect on gastric acid is 5 to 12 times that of cimetidine in terms of moles. Therefore, it is a potent H2 receptor blocker.

66357-59-3 49
Glipizide Tablets
Glipizide.
Name Description Content CAS NO. Registered Holders
Glipizide

1. This product is a second-generation sulfonylurea antidiabetic drug, which is effective for most patients with type 2 diabetes. It can reduce fasting and postprandial blood sugar and reduce glycosylated hemoglobin (HbAlc) by 1% to 2%. 2. The main function of this type of drug is to stimulate the pancreatic b cells to secrete insulin, but the prerequisite is that the pancreatic b cells still have a certain function of synthesizing and secreting insulin. 3. Its mechanism is to specifically bind to the sulfonylurea receptor on the b cell membrane, thereby closing the K channel, causing changes in membrane potential, opening the Ca2 channel, and increasing intracellular Ca2, forcing insulin secretion. 4. In addition, there are extrapancreatic effects, including improving the insulin resistance of peripheral tissues (such as liver, muscle, and fat).

More

1. This product is a second-generation sulfonylurea antidiabetic drug, which is effective for most patients with type 2 diabetes. It can reduce fasting and postprandial blood sugar and reduce glycosylated hemoglobin (HbAlc) by 1% to 2%. 2. The main function of this type of drug is to stimulate the pancreatic b cells to secrete insulin, but the prerequisite is that the pancreatic b cells still have a certain function of synthesizing and secreting insulin. 3. Its mechanism is to specifically bind to the sulfonylurea receptor on the b cell membrane, thereby closing the K channel, causing changes in membrane potential, opening the Ca2 channel, and increasing intracellular Ca2, forcing insulin secretion. 4. In addition, there are extrapancreatic effects, including improving the insulin resistance of peripheral tissues (such as liver, muscle, and fat).

29094-61-9 26
Penicillin V Potassium Tablets
The main ingredient of this product is penicillin V potassium, and its chemical name is (2S, 5R, 6R)-3,3-dimethyl-7-oxo-6-(2-phenoxyacetylamino)-4-thia-1-azabicyclo[3.2.0]-heptane-2-carboxylic acid potassium salt.
Name Description Content CAS NO. Registered Holders
Penicillin V potassium salt

This product is a penicillin antibiotic. The antibacterial spectrum is the same as penicillin. It has antibacterial activity against most Gram-positive bacteria, Gram-negative cocci, individual Gram-negative bacilli (such as Haemophilus), spirochetes and actinomycetes, but most Staphylococcus strains (90%) including Staphylococcus aureus and coagulase-negative Staphylococci can produce β-lactamase to hydrolyze this product and inactivate it. The activity of this product against most sensitive strains is 2 to 5 times weaker than that of penicillin. It has no antibacterial effect on strains that produce penicillinase. The mechanism of action of this product is to inhibit the synthesis of bacterial cell walls, causing the bacteria to rupture and dissolve rapidly.

More

This product is a penicillin antibiotic. The antibacterial spectrum is the same as penicillin. It has antibacterial activity against most Gram-positive bacteria, Gram-negative cocci, individual Gram-negative bacilli (such as Haemophilus), spirochetes and actinomycetes, but most Staphylococcus strains (90%) including Staphylococcus aureus and coagulase-negative Staphylococci can produce β-lactamase to hydrolyze this product and inactivate it. The activity of this product against most sensitive strains is 2 to 5 times weaker than that of penicillin. It has no antibacterial effect on strains that produce penicillinase. The mechanism of action of this product is to inhibit the synthesis of bacterial cell walls, causing the bacteria to rupture and dissolve rapidly.

132-98-9 18
Sulfur ointment
Each gram of this product contains 0.1 gram of sublimated sulfur as the main ingredient. The auxiliary materials are: light liquid paraffin, paraffin, and yellow vaseline.
Name Description Content CAS NO. Registered Holders
Sulfur

It has a killing effect on scabies, bacteria, and fungi, and can remove oil, soften the epidermis, and dissolve keratin. Its mechanism of action is that after sulfur comes into contact with skin and tissue secretions, it produces hydrogen sulfide and pentathionic acid.

More

It has a killing effect on scabies, bacteria, and fungi, and can remove oil, soften the epidermis, and dissolve keratin. Its mechanism of action is that after sulfur comes into contact with skin and tissue secretions, it produces hydrogen sulfide and pentathionic acid.

0.1g 0
PARAFFINUMLIQUIDUMLEVE

This product has a killing effect on scabies, bacteria, and fungi, and can remove oil, soften the epidermis, and dissolve keratin. Its mechanism of action is that after sulfur comes into contact with skin and tissue secretions, it produces hydrogen sulfide and pentathionic acid.

More

This product has a killing effect on scabies, bacteria, and fungi, and can remove oil, soften the epidermis, and dissolve keratin. Its mechanism of action is that after sulfur comes into contact with skin and tissue secretions, it produces hydrogen sulfide and pentathionic acid.

0
Paraffin wax

This product has a killing effect on scabies, bacteria, and fungi, and can remove oil, soften the epidermis, and dissolve keratin. Its mechanism of action is that after sulfur comes into contact with skin and tissue secretions, it produces hydrogen sulfide and pentathionic acid.

More

This product has a killing effect on scabies, bacteria, and fungi, and can remove oil, soften the epidermis, and dissolve keratin. Its mechanism of action is that after sulfur comes into contact with skin and tissue secretions, it produces hydrogen sulfide and pentathionic acid.

8002-74-2 8
Petrolatum

This product has a killing effect on scabies, bacteria, and fungi, and can remove oil, soften the epidermis, and dissolve keratin. Its mechanism of action is that after sulfur comes into contact with skin and tissue secretions, it produces hydrogen sulfide and pentathionic acid.

More

This product has a killing effect on scabies, bacteria, and fungi, and can remove oil, soften the epidermis, and dissolve keratin. Its mechanism of action is that after sulfur comes into contact with skin and tissue secretions, it produces hydrogen sulfide and pentathionic acid.

8009-03-8 18
Pioglitazone Hydrochloride Tablets
The main ingredient of this product is pioglitazone hydrochloride, and its chemical name is (±) 5-[4-[2-(5-ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione hydrochloride.
Name Description Content CAS NO. Registered Holders
Pioglitazone hydrochloride

Thiazolidinediones are antidiabetic drugs that are insulin sensitizers. They regulate the transcription of insulin-related genes that control glucose and lipid metabolism by highly selectively stimulating peroxisome growth factor-activated receptor-γ (PPAR-γ), reducing insulin resistance in peripheral tissues and liver, increasing insulin-dependent glucose processing, and reducing hepatic glucose output.

More

Thiazolidinediones are antidiabetic drugs that are insulin sensitizers. They regulate the transcription of insulin-related genes that control glucose and lipid metabolism by highly selectively stimulating peroxisome growth factor-activated receptor-γ (PPAR-γ), reducing insulin resistance in peripheral tissues and liver, increasing insulin-dependent glucose processing, and reducing hepatic glucose output.

112529-15-4 47
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.